Primary tumour characteristics and axillary lymph node status in breast cancer

被引:41
作者
Yiangou, C [1 ]
Shousha, S
Sinnett, HD
机构
[1] Charing Cross Hosp, Dept Breast Surg, London W6 8RF, England
[2] Charing Cross Hosp, Dept Histopathol, London W6 8RF, England
关键词
axillary lymph nodes; breast cancer; primary tumour characteristics;
D O I
10.1038/sj.bjc.6690629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper examines the correlation between axillary lymph node status and primary tumour characteristics in breast cancer and whether this can be used to select patients for axillary lymphadenectomy. The results are based on a retrospective analysis of 909 patients who underwent axillary dissection in our unit. Axillary lymph nodes containing metastases were found in 406 patients (44.7%), all with invasive carcinomas, but in none of the 37 carcinomas-in-situ. Nodal status was negative in all T1a tumours, but lymph node metastases were present in 16.3% and 35.7% of T1b and T1c tumours respectively. When histological grade was taken into account, positivity for grade I T1b and Tie tumours fell to 13.6% and 26.7% respectively Lymph node metastases were found in 85% of patients with lymphovascular invasion in their tumours as compared to-only 15.4% of those without and in 45.5% of oestrogen and progesterone receptor-positive tumours. When one or both hormone receptors were absent this figure was much higher. it appears that for Tla breast cancers axillary dissection is not necessary, whereas for T1b, T1c and grade I T2 tumours other histopathological parameters should be taken into consideration in deciding who should undergo axillary lymphadenectomy.
引用
收藏
页码:1974 / 1978
页数:5
相关论文
共 44 条
  • [1] Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
    Albertini, JJ
    Lyman, GH
    Cox, C
    Yeatman, T
    Balducci, L
    Ku, NN
    Shivers, S
    Berman, C
    Wells, K
    Rapaport, D
    Shons, A
    Horton, J
    Greenberg, H
    Nicosia, S
    Clark, R
    Cantor, A
    Reintgen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1818 - 1822
  • [2] [Anonymous], 1992, SURG ONCOLOGY CLIN
  • [3] Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose
    Avril, N
    Dose, J
    Janicke, F
    Ziegler, S
    Romer, W
    Weber, W
    Herz, M
    Nathrath, W
    Graeff, H
    Schwaiger, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) : 1204 - 1209
  • [4] Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO
  • [5] 2-Y
  • [6] BENSON EA, 1986, EUR J SURG ONCOL, V12, P267
  • [7] AXILLARY LYMPH-NODE METASTASES IN BREAST-CANCER - PREOPERATIVE DETECTION WITH US
    BRUNETON, JN
    CARAMELLA, E
    HERY, M
    AUBANEL, D
    MANZINO, JJ
    PICARD, JL
    [J]. RADIOLOGY, 1986, 158 (02) : 325 - 326
  • [8] CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO
  • [9] 2-I
  • [10] VALUE OF AXILLARY DISSECTION IN ADDITION TO LUMPECTOMY AND RADIOTHERAPY IN EARLY BREAST-CANCER
    CABANES, PA
    SALMON, RJ
    VILCOQ, JR
    DURAND, JC
    FOURQUET, A
    GAUTIER, C
    ASSELAIN, B
    [J]. LANCET, 1992, 339 (8804) : 1245 - 1248